Results 281 to 290 of about 309,486 (308)

Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT

Clinics and Research in Hepatology and Gastroenterology, 2021
Qing Xie, Da-zhi Zhang, Gui-qiang Wang
exaly  

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

PLoS Medicine, 2022
David M Lowe, Kashfia Chowdhury, Stephanie Davey   +2 more
exaly  

Antiviral Therapy

2023
Dr Graham Darby, Dr Gerlad Gough, Dr Margaret Tisdale, Dr Eddie Littler, Prof D J Rowlands, Dr Eddie Blair   +5 more
openaire   +1 more source

<p>Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients</p>

Drug Design, Development and Therapy, 2020
Lu Li, Saiping Jiang, Xiaoyang Lu
exaly  

Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy

Biomedicine and Pharmacotherapy, 2021
Hassan Nosrati, Jalal Heshmatnia, Reza Falak   +2 more
exaly  

Antiviral Therapy

2008
Frank L. Tomaka, Roger J. Pomerantz
  +4 more sources

Ocular Antiviral Therapy

International Ophthalmology Clinics, 1980
openaire   +2 more sources

Antiviral therapy

Nature, 1995
Andrew N Phillips, Caroline A Sabin, Amanda Mocroft, George Janossy   +3 more
openaire   +1 more source

Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation

Journal of Hepatology, 2007
Massimo De Luca
exaly  

Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus

Inflammatory Bowel Diseases, 2015
David H Bruining, Edward V Loftus
exaly